Cytarska Joanna, Misiura Konrad, Filip-Psurska Beata, Wietrzyk Joanna
Department of Chemical Technology of Pharmaceuticals, Collegium Medicum, Nicolaus Copernicus University, Jurasza 2, 85-094 Bydgoszcz, Poland.
Acta Pol Pharm. 2013 May-Jun;70(3):481-7.
A series of new prodrugs: [bis(2-chloroethylamino)phosphoryloxy]methyl acetate, [bis(2-chloroethylamino)phosphoryloxy]methyl pivalate and [bis(2-chloroethylamino)phosphoryloxy]methyl benzoate, was obtained in the reaction of isophosphoramide mustard (iPAM) with the corresponding acyloxymethyl halides. The cytotoxic activity of these new compounds is also shown. All compounds were highly active in the inhibition of cancer cell proliferation against the human lung (A594), prostate (PC-3) and breast (MCF-7) cancer cell lines.
[双(2-氯乙氨基)磷酰氧基]甲基乙酸酯、[双(2-氯乙氨基)磷酰氧基]甲基新戊酸酯和[双(2-氯乙氨基)磷酰氧基]甲基苯甲酸酯,是通过异环磷酰胺氮芥(iPAM)与相应的酰氧基甲基卤化物反应制得的。还展示了这些新化合物的细胞毒性活性。所有化合物在抑制人肺癌(A594)、前列腺癌(PC-3)和乳腺癌(MCF-7)细胞系的癌细胞增殖方面均具有高活性。